Accardo v. Cenac

722 So. 2d 302, 1998 WL 781784
CourtLouisiana Court of Appeal
DecidedNovember 6, 1998
Docket97 CA 2320
StatusPublished
Cited by11 cases

This text of 722 So. 2d 302 (Accardo v. Cenac) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Accardo v. Cenac, 722 So. 2d 302, 1998 WL 781784 (La. Ct. App. 1998).

Opinion

722 So.2d 302 (1998)

Lou Costanza ACCARDO, Oscar Joseph Accardo, Tammy Lynn Accardo and Rodney Joseph Accardo
v.
Dr. Louis CENAC a/k/a Dr. Phillip L. Cenac, Cenac/Davis Psychiatric Group, E.R. Squibb and Son, Inc. d/b/a Olin Corporation, (Manufacturer of Prolixin), Princeton Pharmaceutical Company (Distributor of Prolixin), Legion Insurance Company, The Louisiana Patients Compensation Fund, ABC Insurance Company, and XYZ Insurance Company.

No. 97 CA 2320.

Court of Appeal of Louisiana, First Circuit.

November 6, 1998.

*303 Kevin P. Landreneau, Daniel J. McGlynn, Christopher D. Glisson, Anthony M. Fazzio, Baton Rouge, Counsel for Plaintiffs Lou Costanza Accardo, Oscar Joseph Accardo, Tammy Lynn Accardo, Rodney Joseph Accardo.

Elaine W. Selle, New Orleans, Counsel for Intervenor Louisiana Patient's Compensation Fund.

*304 Elaine W. Selle, New Orleans, Bradley C. Myers, Baton Rouge, Counsel for Defendants Dr. Louis Cenac, Cenac/Davis Psychiatric Group, Legion Insurance Company.

Before LeBLANC, FOGG and PARRO, JJ.

LeBLANC, Judge.

This is a medical malpractice action in which the defendant, Dr. Louis Cenac, stipulated to liability and causation during the course of the trial, leaving only the issue of damages for the jury. The jury returned a verdict awarding the plaintiff, Lou Costanza Accardo, $100,000 in general damages, $25,000 in loss of income, $22,000 in past medical expenses, and $1,100,000 in future medical expenses; her husband, Mr. Oscar Accardo was awarded $50,000 for his loss of consortium, and the Accardo's two children were awarded $15,000 each for their loss of consortium. A judgment was rendered awarding the plaintiffs a total of $227,000. (As discussed more fully below, the $1,100,000 for future medical expenses was excluded from the judgment.) Plaintiffs sought an additur, and in the alternative, a new trial. The trial court granted plaintiffs' motion for additur, awarding an additional $150,000 in general damages. A reformed judgment increasing the damage award by $150,000 was rendered; this appeal, by the plaintiffs, Mr. and Mrs. Accardo and their two children, Tammy and Rodney, and the defendant/intervenor, Louisiana Patients' Compensation Fund (LPCF), follows.

FACTS

In short, as treatment for her paranoid schizophrenia, Mrs. Accardo received injections of Prolixin as prescribed and administered by Dr. Cenac over a period of five years, from October 1983 to August 1988. Prolixin is a neuroleptic drug known to cause the adverse side effect of tardive dyskinesia, a permanent and irreversible neurological disorder. In November, 1988, at the age of forty-three, Mrs. Accardo was diagnosed with severe tardive dyskinesia, contracted as a direct result of neuroleptic medication.

Factual Background

In 1970, Mrs. Accardo had a miscarriage. In 1974, she suffered an ectopic (tubal) pregnancy. Shortly thereafter, she began feeling depressed and after seeking counseling from a priest, she began experiencing auditory and tactile hallucinations taking the form of the priest touching her and being inside her head, talking to her. In 1979, approximately five years after the depression and hallucinations began, her family physician, Dr. Vincent Bella, referred her to the defendant, Dr. Louis Cenac, for psychiatric treatment. According to Dr. Cenac, he saw Mrs. Accardo twice in 1979, at which time he found her to be psychotic and laboring under delusions about a priest. During the second visit, Mrs. Accardo expressed a desire to be seen by a female psychiatrist; Dr. Cenac referred her to Dr. Jeanne Estes.

Dr. Estes diagnosed Mrs. Accardo with schizophrenia, paranoid type, and prescribed the neuroleptic drug, Haldol, (later switched to Mellaril) and Artane, for possible side effects from the neuroleptic drugs. Dr. Estes continued to treat Mrs. Accardo with the neuroleptic medications through 1981, during which time Mrs. Accardo continued to have hallucinations, thought disorder, and depression. In late 1981, due to a change in insurance coverage, Mrs. Accardo discontinued treatment with Dr. Estes and sought treatment at Stanacola Medical. There she was referred back to Dr. Cenac, who was a psychiatric consultant for Stanacola, for continued treatment for her "paranoid feelings."

Dr. Cenac examined Mrs. Accardo on September 14, 1981, at which time she complained of having an obsession that a priest had control of her mind, her thoughts were all jumbled up and she felt that the right side of her brain was blocked out. Dr. Cenac noted that Mrs. Accardo had not been taking the medicine prescribed for her by Dr. Estes. He administered psychological testing which revealed symptoms of schizophrenia and obsessive-compulsive disease, as well as signs of depression. Dr. Cenac diagnosed Mrs. Accardo with schizophrenia, paranoid type, and prescribed Triavil, which is a composite medication consisting of an antidepressant, to help control her moods, and a neuroleptic for *305 her schizophrenia. Dr. Cenac also referred her and her husband for supportive counseling. He saw her again in August, 1982, at which time she continued to have paranoid delusions and had quit taking her medication. He, again, prescribed Triavil and continued to see Mrs. Accardo.

In October, 1983, Dr. Cenac began treating Mrs. Accardo with a monthly dose of Prolixin Decanoate, a timed-release injection of another type of neuroleptic drug to help reduce the intensity of her hallucinations. She received her first injection of 1cc Prolixin on October 17, 1983, and continued to receive the same dosage on an approximate monthly basis[1] for the next five years. Dr. Cenac's medical record for Mrs. Accardo is scant;[2] however, it reflects that Mrs. Accardo's hallucinations, thought disorder, and depression continued throughout this time. He noted instances in which she developed some stiffness, which he diagnosed as "pseudoparkinsonian symptoms" (another known side effect of neuroleptic medications) for which he prescribed Artane. Mrs. Accardo received her last injection of Prolixin on August 4, 1988. Although Mrs. Accardo was diagnosed with severe tardive dyskinesia on November 28, 1988, Dr. Cenac testified that during the five years in which Mrs. Accardo came in for her injections, he did not note any signs or symptoms associated with tardive dyskinesia, even as late as November 1988. Nevertheless, on November 28, 1988, Dr. Cenac examined Mrs. Accardo and observed a "buccal, oral, [and] facial dyskinesia", which he diagnosed as tardive dyskinesia. In a letter, dated that same day, to Mrs. Accardo's general practitioner, Dr. Bella, Dr. Cenac noted, "I explained the gravity of the condition to her husband and that it may have been due to the major tranquilizers [which he testified were the neuroleptic drugs, including the Prolixin]." Dr. Cenac discontinued the Prolixin and prescribed Diazepam (Valium) to "calm her." In a letter to Dr. Bella dated December 2, 1988, Dr. Cenac noted the continuation of Mrs. Accardo's "buccal, oral and tongue movements" as well as "dyscontrol of her grimacing and eye movements," overall restlessness and hand wringing. Dr. Cenac did not see or treat Mrs. Accardo after December, 1988.

Subsequent to the tardive dyskinesia diagnosis, from 1989 to 1991, Mrs. Accardo required hospitalization on five separate occasions for her schizophrenia together with the tardive dyskinesia. Mrs. Accardo resumed treatment with Dr. Estes in August, 1990, and continuing through the date of trial.

The record contains evidence, particularly the testimony of Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Falterman v. Schunemeyer
153 So. 3d 1284 (Louisiana Court of Appeal, 2014)
Elizabeth Falterman v. Amy Schunemeyer, Dpm
Louisiana Court of Appeal, 2014
Sloan v. Mouton
82 So. 3d 364 (Louisiana Court of Appeal, 2011)
Cece Sloan v. Renee Mouton
Louisiana Court of Appeal, 2011
Temple v. State ex rel. Department of Transportation & Development
858 So. 2d 569 (Louisiana Court of Appeal, 2003)
Temple v. STATE EX REL. DOTD
858 So. 2d 569 (Louisiana Court of Appeal, 2003)
Cox v. Julian
846 So. 2d 986 (Louisiana Court of Appeal, 2003)
Coleman v. Deno
832 So. 2d 1016 (Louisiana Court of Appeal, 2002)
Keener v. Mid-Continent Cas.
817 So. 2d 347 (Louisiana Court of Appeal, 2002)
Magee v. Pittman
761 So. 2d 731 (Louisiana Court of Appeal, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
722 So. 2d 302, 1998 WL 781784, Counsel Stack Legal Research, https://law.counselstack.com/opinion/accardo-v-cenac-lactapp-1998.